Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

New analysis reveals flaws in traditional BMI classification system

27

Mar 2026

New analysis reveals flaws in traditional BMI classification system

Research from Italy to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) and published in the journal Nutrients shows that when the gold standard technique of dual-energy X-ray absorptiometry (DXA) is used to measure body fat in the general population, it shows that the traditional WHO body mass index (BMI) classification system misidentifies significant numbers of people as having overweight or obesity.

New mother’s experience highlights importance of postpartum heart care

27

Mar 2026

New mother’s experience highlights importance of postpartum heart care

At 35, Brooklyn resident Luyba Caloras was healthy, with no history of heart problems and no reason to think she was at risk of them. But pregnancy can act as a stress test on the heart—and soon after delivering her son at NYU Langone Health on February 3, 2024, she was diagnosed with a complication she never expected.

UStudy links diagnostic timing to ovarian cancer survival outcomes

27

Mar 2026

UStudy links diagnostic timing to ovarian cancer survival outcomes

The study "Diagnostic Timing and Ovarian Cancer Survival in North Carolina" has been published in the latest issue of JAMA Network Open. Led by a team of UNC-Chapel Hill researchers, this study explored the relationship between survival and how quickly patients are diagnosed with ovarian cancer.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.